What the Options Market Tells Us About Iovance Biotherapeutics
What the Options Market Tells Us About Iovance Biotherapeutics
Investors with a lot of money to spend have taken a bullish stance on Iovance Biotherapeutics (NASDAQ:IOVA).
资金雄厚的投资者看好iovance biotherapeutics（纳斯达克：IOVA）的前景。
And retail traders should know.
零售交易者应该知道。
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
我们在这里追踪的公开期权历史记录中发现，今天这些头寸已经出现了。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IOVA, it often means somebody knows something is about to happen.
无论是机构还是富人，我们都不知道。但当iovance biotherapeutics出现这样大的变化时，通常意味着某些人知道即将发生的事情。
Today, Benzinga's options scanner spotted 8 options trades for Iovance Biotherapeutics.
今天，Benzinga的期权扫描器发现了iovance biotherapeutics的8次期权交易。
This isn't normal.
这不正常。
The overall sentiment of these big-money traders is split between 75% bullish and 12%, bearish.
这些大额交易者的整体情绪在75%看涨和12%看跌之间分化。
Out of all of the options we uncovered, there was 1 put, for a total amount of $73,060, and 7, calls, for a total amount of $536,781.
在我们发现的所有期权中，有1个看跌，总额为73,060美元，还有7个看涨，总额为536,781美元。
Expected Price Movements
预期价格波动
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $7.0 to $9.0 for Iovance Biotherapeutics over the recent three months.
根据交易活动情况，看来重要的投资者在最近三个月中瞄准iovance biotherapeutics的目标价从7.0到9.0的价格区间。
Analyzing Volume & Open Interest
分析成交量和未平仓合约
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Iovance Biotherapeutics's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Iovance Biotherapeutics's substantial trades, within a strike price spectrum from $7.0 to $9.0 over the preceding 30 days.
评估成交量和持仓量是期权交易的战略步骤。这些指标揭示了投资者对iovance biotherapeutics指定行权价下期权的流动性和兴趣。即将公布的数据可视化了在过去30天内，iovance biotherapeutics的看涨和看跌期权的成交量和持仓量的波动情况，这些期权与目标价在7.0到9.0之间的大规模交易有关。
Iovance Biotherapeutics 30-Day Option Volume & Interest Snapshot
iovance biotherapeutics 30天期权成交量和持仓量快照
Biggest Options Spotted:
最大的期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA | CALL | SWEEP | BULLISH | 08/09/24 | $0.9 | $0.75 | $0.9 | $8.00 | $147.5K | 2.4K | 1.9K |
| IOVA | CALL | SWEEP | BULLISH | 08/09/24 | $0.85 | $0.8 | $0.85 | $8.00 | $97.2K | 2.4K | 2.8K |
| IOVA | CALL | SWEEP | BULLISH | 08/09/24 | $0.9 | $0.65 | $0.9 | $8.00 | $77.5K | 2.4K | 1.9K |
| IOVA | PUT | TRADE | BEARISH | 08/09/24 | $0.65 | $0.55 | $0.65 | $7.00 | $73.0K | 5.3K | 1.5K |
| IOVA | CALL | SWEEP | BULLISH | 08/09/24 | $0.9 | $0.65 | $0.9 | $8.00 | $63.2K | 2.4K | 5.3K |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA | 看涨 | SWEEP | 看好 | 08/09/24 | $0.9 | 0.75美元 | $0.9 | 8.00美元 | $147.5K | 2.4K | 1.9K |
| IOVA | 看涨 | SWEEP | 看好 | 08/09/24 | $0.85 | $0.8 | $0.85 | 8.00美元 | $97.2K | 2.4K | 2.8K |
| IOVA | 看涨 | SWEEP | 看好 | 08/09/24 | $0.9 | $0.65 | $0.9 | 8.00美元 | $77.5K | 2.4K | 1.9K |
| IOVA | 看跌 | 交易 | 看淡 | 08/09/24 | $0.65 | $0.55 | $0.65 | $7.00 | $73.0K | 5.3K | 1.5K |
| IOVA | 看涨 | SWEEP | 看好 | 08/09/24 | $0.9 | $0.65 | $0.9 | 8.00美元 | $63.2K | 2.4K | 5.3K |
About Iovance Biotherapeutics
iovance biotherapeutics简介
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
iovance biotherapeutics公司是一家临床阶段的生物制药公司，通过利用个性化治疗方法，利用人类免疫系统识别和摧毁各种癌细胞，开创了治疗癌症的转型方法。公司正在为首个自体t细胞治疗癌症实现潜在的美国监管批准和商业化做准备，其目标是成为创新、开发和交付固体肿瘤癌症肿瘤浸润淋巴细胞（TIL）疗法的领导者。
In light of the recent options history for Iovance Biotherapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鉴于iovance biotherapeutics的最近期权历史，将焦点放在公司本身是合适的。我们旨在探讨公司的当前表现。
Where Is Iovance Biotherapeutics Standing Right Now?
iovance biotherapeutics现在处于什么位置？
- Trading volume stands at 9,215,688, with IOVA's price up by 25.78%, positioned at $9.22.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 0 days.
- 交易量为9,215,688股，IOVA的价格上涨了25.78%，位于9.22美元。
- RSI指标显示该股票目前处于超买和超卖之间的中立状态。
- 预计在0天内公布收益报告。
Professional Analyst Ratings for Iovance Biotherapeutics
iovance biotherapeutics的专业分析师评级
1 market experts have recently issued ratings for this stock, with a consensus target price of $10.0.
1位市场专家最近对该股票进行了评级，目标价平均为10.0美元。
- An analyst from Piper Sandler downgraded its action to Neutral with a price target of $10.
- Piper Sandler的一名分析师将其行动下调至中立，目标价为10美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Iovance Biotherapeutics with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供更高的利润潜力。精明的交易者通过持续的教育、战略性的交易调整、利用各种因子和保持敏感以市场动态的特点来缓解这些风险。通过Benzinga Pro获得iovance biotherapeutics最新的期权交易，以获取实时警报。